Corteva (NYSE:CTVA) Upgraded at JPMorgan Chase & Co.

JPMorgan Chase & Co. upgraded shares of Corteva (NYSE:CTVA) from a neutral rating to an overweight rating in a research report released on Tuesday morning, Marketbeat.com reports. JPMorgan Chase & Co. currently has $19.00 price objective on the stock.

Several other equities analysts also recently weighed in on the company. BMO Capital Markets set a $15.00 target price on Corteva in a research report on Friday, October 2nd. Royal Bank Of Canada reissued an “outperform” rating and issued a $103.00 price objective on shares of Corteva in a research note on Wednesday, September 16th. Argus reaffirmed a “buy” rating and set a $91.00 target price on shares of Corteva in a research note on Friday, September 18th. Mizuho upped their target price on shares of Corteva from $96.00 to $97.00 and gave the stock an “outperform” rating in a report on Tuesday, July 14th. Finally, UBS Group raised their price target on shares of Corteva from $85.00 to $90.00 and gave the stock a “neutral” rating in a research note on Wednesday, September 16th. Sixteen research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $64.00.

Corteva Stock Down 5.5%

CTVA stock opened at $13.66 on Tuesday. Corteva has a 52 week low of $11.74 and a 52 week high of $90.97. The company has a quick ratio of 1.10, a current ratio of 1.52 and a debt-to-equity ratio of 0.07. The firm has a 50-day simple moving average of $72.79 and a 200-day simple moving average of $78.74. The stock has a market capitalization of $9.12 billion, a P/E ratio of 9.05, a P/E/G ratio of 1.25 and a beta of 0.57.

Corteva (NYSE:CTVA) last issued its quarterly earnings results on Thursday, July 30th. The company reported $2.30 earnings per share for the quarter, beating analysts’ consensus estimates of $2.24 by $0.06. Corteva had a net margin of 5.66% and a return on equity of 10.18%. The firm had revenue of $6.38 billion for the quarter, compared to analyst estimates of $6.60 billion. During the same period last year, the company posted $2.20 EPS. Corteva’s quarterly revenue was down 1.2% compared to the same quarter last year. Corteva has set its FY 2026 guidance at 3.600-3.800 EPS. Equities analysts forecast that Corteva will post 1.69 earnings per share for the current fiscal year.

Corteva Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, September 15th. Investors of record on Tuesday, September 1st were issued a $0.18 dividend. The ex-dividend date of this dividend was Tuesday, September 1st. This represents a $0.72 dividend on an annualized basis and a dividend yield of 5.3%. Corteva’s dividend payout ratio is currently 47.68%.

Hedge Funds Weigh In On Corteva

Institutional investors and hedge funds have recently bought and sold shares of the company. EFG International AG acquired a new stake in shares of Corteva during the 2nd quarter worth approximately $25,000. Compass Financial Management LLC acquired a new position in Corteva in the second quarter valued at approximately $25,000. Elevation Wealth Partners LLC lifted its holdings in Corteva by 334.6% in the second quarter. Elevation Wealth Partners LLC now owns 339 shares of the company’s stock valued at $29,000 after acquiring an additional 261 shares during the last quarter. Clearstead Trust LLC purchased a new position in Corteva in the second quarter worth approximately $31,000. Finally, N.E.W. Advisory Services LLC acquired a new stake in Corteva during the second quarter worth $33,000. 81.54% of the stock is currently owned by institutional investors and hedge funds.

More Corteva News

Here are the key news stories impacting Corteva this week:

• Positive Sentiment: KeyBanc upgraded Corteva to Overweight after the Vylor separation and set a $17 price target. The firm expects the streamlined company could achieve “meaningful” earnings growth after 2027, potentially supporting a re-rating of the shares. Corteva upgraded at KeyBanc after spinoff of Vylor
• Positive Sentiment: Options activity was unusually bullish, with investors purchasing 5,408 call options—more than five times typical daily volume. This indicates increased speculative interest in a potential recovery, although options activity is not a guarantee of future performance.
• Positive Sentiment: Commentator Jim Cramer said he would be comfortable building a position in Vylor, the spun-off seed business, suggesting the separation may make the higher-quality growth assets more attractive to investors. However, he remained cautious on Corteva’s crop-protection operations. Jim Cramer Sees One Stock to Own After Corteva’s Breakup
• Neutral Sentiment: KeyCorp maintained an Overweight rating and a $17 target, but its analyst projected only $1.60 in FY2029 EPS. That estimate is below the current-year consensus of $2.77, highlighting uncertainty over the pace and durability of post-spinoff earnings growth.
• Negative Sentiment: Zacks Research downgraded Corteva from Hold to Strong Sell, creating a significant counterweight to the KeyBanc upgrade and likely contributing to investor caution. Corteva Downgraded by Zacks Research

Corteva Company Profile

Corteva, Inc is an agriculture-focused company that develops and supplies seed, crop protection and digital agriculture products. Its offerings are designed to help farmers improve crop productivity, manage pests and diseases, and support more efficient and sustainable farming practices.

The company’s seed portfolio includes corn, soybean, wheat, sunflower, canola, cotton and other crops, marketed through brands such as Pioneer, Brevant seeds and PhytoGen. Corteva also provides herbicides, insecticides, fungicides, biological products and seed treatments under a range of agricultural brands.

Corteva serves farmers, agricultural retailers and other customers in markets around the world.